webinar register page

Webinar banner
Generation-HD1 Trial News: What does this mean and where do we go from here?
Please join us for a discussion of the recent disappointing news that the Roche/Genentech Generation-HD1 trial has stopped dosing its drug (tominersen). Jennifer Simpson, LCSW (Assistant Director of Youth and Community Services at HDSA), George Yohrling, PhD (Chief Scientific and Mission Officer at HDSA) and Vicki Wheelock, MD (HDSA Center of Excellence Director at UC-Davis and Site Investigator for the Generation-HD1 trial) will participate in the discussion and take questions from audience.

Mar 25, 2021 11:00 AM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: HDSA HDSA.